Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1966 2
1967 5
1968 7
1969 4
1970 2
1971 6
1972 14
1973 12
1974 14
1975 8
1976 9
1977 6
1978 8
1979 8
1980 23
1981 13
1982 15
1983 14
1984 18
1985 21
1986 26
1987 22
1988 42
1989 28
1990 38
1991 36
1992 38
1993 63
1994 52
1995 84
1996 85
1997 50
1998 55
1999 72
2000 95
2001 81
2002 85
2003 71
2004 76
2005 71
2006 84
2007 75
2008 77
2009 99
2010 99
2011 98
2012 107
2013 99
2014 93
2015 125
2016 116
2017 124
2018 114
2019 109
2020 134
2021 139
2022 135
2023 151
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

3,136 results

Results by year

Filters applied: . Clear all
Page 1
Hypertrophic Cardiomyopathy: An Overview of Genetics and Management.
Teekakirikul P, Zhu W, Huang HC, Fung E. Teekakirikul P, et al. Biomolecules. 2019 Dec 16;9(12):878. doi: 10.3390/biom9120878. Biomolecules. 2019. PMID: 31888115 Free PMC article. Review.
Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous cardiac muscle disorder with a diverse natural history, characterized by unexplained left ventricular hypertrophy (LVH), with histopathological hallmarks including myocyte enlargement, myocyte disarray …
Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous cardiac muscle disorder with a diverse natural history, chara …
Hypertrophic cardiomyopathy: the future of treatment.
Tuohy CV, Kaul S, Song HK, Nazer B, Heitner SB. Tuohy CV, et al. Eur J Heart Fail. 2020 Feb;22(2):228-240. doi: 10.1002/ejhf.1715. Epub 2020 Jan 9. Eur J Heart Fail. 2020. PMID: 31919938 Free article. Review.
Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic disorder most often caused by sarcomeric mutations resulting in left ventricular hypertrophy, fibrosis, hypercontractility, and reduced compliance. ...
Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic disorder most often caused by sarcomeric mutations resulting in l …
Hypertrophic cardiomyopathy.
Maron BJ, Maron MS. Maron BJ, et al. Lancet. 2013 Jan 19;381(9862):242-55. doi: 10.1016/S0140-6736(12)60397-3. Epub 2012 Aug 6. Lancet. 2013. PMID: 22874472 Review.
Hypertrophic cardiomyopathy is a common inherited cardiovascular disease present in one in 500 of the general population. ...A subgroup of patients with genetic mutations but without left-ventricular hypertrophy has emerged, with unresolved natural history. Now, aft …
Hypertrophic cardiomyopathy is a common inherited cardiovascular disease present in one in 500 of the general population. ...A …
Circulating Biomarkers in Hypertrophic Cardiomyopathy.
Matthia EL, Setteducato ML, Elzeneini M, Vernace N, Salerno M, Kramer CM, Keeley EC. Matthia EL, et al. J Am Heart Assoc. 2022 Dec 6;11(23):e027618. doi: 10.1161/JAHA.122.027618. Epub 2022 Nov 16. J Am Heart Assoc. 2022. PMID: 36382968 Free PMC article. Review.
Hypertrophic cardiomyopathy is the most common genetic heart disease. ...We present an updated review of circulating biomarkers in hypertrophic cardiomyopathy representing key pathologic processes including wall stretch, myocardial necrosis, fibrosis, …
Hypertrophic cardiomyopathy is the most common genetic heart disease. ...We present an updated review of circulating biomarker …
Hypertrophic obstructive cardiomyopathy.
Veselka J, Anavekar NS, Charron P. Veselka J, et al. Lancet. 2017 Mar 25;389(10075):1253-1267. doi: 10.1016/S0140-6736(16)31321-6. Epub 2016 Nov 30. Lancet. 2017. PMID: 27912983 Review.
Hypertrophic obstructive cardiomyopathy is an inherited myocardial disease defined by cardiac hypertrophy (wall thickness 15 mm) that is not explained by abnormal loading conditions, and left ventricular obstruction greater than or equal to 30 mm Hg. ...
Hypertrophic obstructive cardiomyopathy is an inherited myocardial disease defined by cardiac hypertrophy (wall thickness 15 m …
Hypertrophic cardiomyopathy: part 1 - introduction, pathology and pathophysiology.
Varma PK, Neema PK. Varma PK, et al. Ann Card Anaesth. 2014 Apr-Jun;17(2):118-24. doi: 10.4103/0971-9784.129841. Ann Card Anaesth. 2014. PMID: 24732610 Review.
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease with many genotype and phenotype variations. Earlier terminologies, hypertrophic obstructive cardiomyopathy and idiopathic hypertrophic sub-aortic stenosis are n …
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease with many genotype and phenotype variation …
Hypertrophic cardiomyopathy: a systematic review.
Maron BJ. Maron BJ. JAMA. 2002 Mar 13;287(10):1308-20. doi: 10.1001/jama.287.10.1308. JAMA. 2002. PMID: 11886323 Review.
CONTEXT: Throughout the past 40 years, a vast and sometimes contradictory literature has accumulated regarding hypertrophic cardiomyopathy (HCM), a genetic cardiac disease caused by a variety of mutations in genes encoding sarcomeric proteins and characterized by a …
CONTEXT: Throughout the past 40 years, a vast and sometimes contradictory literature has accumulated regarding hypertrophic cardio …
Hypertrophic Cardiomyopathy in RASopathies: Diagnosis, Clinical Characteristics, Prognostic Implications, and Management.
Lioncino M, Monda E, Verrillo F, Moscarella E, Calcagni G, Drago F, Marino B, Digilio MC, Putotto C, Calabrò P, Russo MG, Roberts AE, Gelb BD, Tartaglia M, Limongelli G. Lioncino M, et al. Heart Fail Clin. 2022 Jan;18(1):19-29. doi: 10.1016/j.hfc.2021.07.004. Epub 2021 Oct 25. Heart Fail Clin. 2022. PMID: 34776080 Free PMC article. Review.
Diagnosis of RASopathy can be triggered by clinical clues ("red flags") which may direct the clinician toward a specific gene test. Compared with sarcomeric hypertrophic cardiomyopathy, hypertrophic cardiomyopathy in RASopathies (R-HCM) is associated w …
Diagnosis of RASopathy can be triggered by clinical clues ("red flags") which may direct the clinician toward a specific gene test. Compared …
Cardiology: hypertrophic cardiomyopathy.
Medical Masterclass contributors; Firth J. Medical Masterclass contributors, et al. Clin Med (Lond). 2019 Jan;19(1):61-63. doi: 10.7861/clinmedicine.19-1-61. Clin Med (Lond). 2019. PMID: 30651247 Free PMC article. Review. No abstract available.
3,136 results